Crossmark

Determinants of epigenetic resistance to HDAC inhibitors in dystrophic fibro‐adipogenic progenitors

Crossref DOI link: https://doi.org/10.15252/embr.202254721

Published Online: 2022-04-04

Published Print: 2022-06-07

Update policy: https://doi.org/10.1002/crossmark_policy

Authors

Consalvi, Silvia https://orcid.org/0000-0002-8640-8212
Tucciarone, Luca

Macrì, Elisa https://orcid.org/0000-0001-9232-0578
De Bardi, Marco https://orcid.org/0000-0001-8217-970X
Picozza, Mario https://orcid.org/0000-0002-2529-6456
Salvatori, Illari

Renzini, Alessandra https://orcid.org/0000-0002-4265-7188
Valente, Sergio https://orcid.org/0000-0002-2241-607X
Mai, Antonello https://orcid.org/0000-0001-9176-2382
Moresi, Viviana https://orcid.org/0000-0003-1912-0339
Puri, Pier Lorenzo https://orcid.org/0000-0003-4964-0095
Funding

Funding for this research was provided by:

Muscular Dystrophy Association (418870)

National Institutes of Health (R01AR076247‐01)
License Information

Version of Record valid from 2022-04-04
More Information

Publication History

Received: 2022-01-24

Accepted: 2022-03-23

Published: 2022-04-04